There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Triple-negative breast cancer (estrogen receptor-negative, progesterone receptor-negative,
and HER2-negative) is a high risk breast cancer that lacks the benefit of specific
therapy that targets these proteins.